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Abstract 
Background: The opioid epidemic in rural New Hampshire requires immediate intervention. 
Treatment for overdoses of opioids with naloxone (an opioid antagonist) must be quickly 
administered to prevent a death in the opioid overdosed patient. Two rural New Hampshire 
clinics did not stock naloxone in their code carts, nor did they have a clinical protocol guiding 
pre- and post-resuscitation in the case of overdose. Purpose: This DNP project introduced 
naloxone into each clinic code cart as well as providing nurses, nurse practitioners and 
physicians education on administering naloxone intra nasal atomizer along with a clinical 
protocol for pre-and post-resuscitation to prevent death from an opioid overdose. Methods: 
Clinic staff members were educated on the use of naloxone pre-and post-resuscitation protocols. 
An SPSS (version 24) statistical program was used to evaluate changes in clinic staff knowledge 
pre-and post-education on the care of the opioid overdosed patient. Results: Pre- and post-testing 
of knowledge of clinic staff demonstrated an increase of knowledge from an average pre-testing 
score of 72% to post-testing of 100% in the thirty-four of the thirty-five participants (with one 
participant scoring 81%). Conclusion: This DNP project developed an education program for 
nurses, nurse practitioners and physicians that clearly improved confidence, knowledge and 
skills allowing for accurate diagnosis and treatment of the non-medical use of prescription 
overdosed patients in two New Hampshire rural clinics This new protocol is reducing deaths 
from opioid overdose.    
      Keywords: Heroin, opioids, overdose, epidemic, naloxone. 
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Introduction and Background 
The American Society of Addiction Medicine (ASAM, 2016) reports that, drug overdose 
is the leading cause of accidental death in the US, with 52, 404 lethal drug overdoses occurring 
in 2015. Opioid addiction is driving the epidemic, with over 20,101 deaths related to prescription 
pain relievers and over 12,990 overdose deaths related to heroin (ASAM, 2016). “How do 
healthcare practitioners translate new knowledge into specific actions that they put into practice 
is a question worth asking” (White & Dudley-Brown, 2012, p.25, para 2). Most practicing 
Family Nurse Practitioners have daily schedules filled with patients that are being examined for 
health screening, routine follow-up care, and for being sicker than expected. This takes time to 
sort out the acute verses chronic disease process.  
Practicing Family Nurse Practitioners spend many hours sifting through laboratory 
results, other tests, imaging and the patient’s symptoms to provide the best possible health care. 
This leads to the symptom’s resolution and or stabilizing the symptoms, thus, preventing death.  
Without knowledge of current research, promotion and initiation of a standard of care and policy 
to improve patient outcome, more patients can die. As such, it is necessary to mention White and 
Dudley-Brown’s (2012) perspective, who claims that “the key to this learning and adoption of 
new knowledge is the use of appropriate implementation strategies” (p.25, para 4).  
In the process of presenting its evidence, this DNP project focused on the utilization of 
theoretical and conceptual frameworks, while suggesting a protocol and intervention that could 
save lives of the non-medical use of prescription opioids overdose patient who come to the 
clinic. Previously, naloxone was used in hospital settings for acutely ill patients as part of pain 
management, such as reversal of conscious sedation effects during procedures like colonoscopy. 
Naloxone was not used as an outpatient antidote for heroin and opioid overdose.  
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Individuals ages twelve and older are plagued by addiction and dying unnecessarily. 
Heroin use has increased among men and women of all ages. Some of the greatest increases are 
groups previously known for low rates of use such as women, privately insured, and the higher 
income people (Center for Disease Control and Prevention [CDC], 2016). Between 1999 and 
2014, the rate of overdose deaths from opioids more than quadrupled. Overdoses involving 
opioids killed more than 28, 000 people in 2014 (CDC, 2015). From 2000 to 2015 more than half 
a million-people died from drug overdoses, 91 Americans die every day from and opioid 
overdose (CDC, 2015). In addition, the New Hampshire (NH) office for the Chief Medical 
Examiner reported 439 deaths for the year 2015, which excluded the number of lives saved 
simply by intervening with naloxone.  
The 2016 projected deaths are expected to be greater than 480. In April 2016, the NH 
Drug Monitoring Initiative (DMI) reported that the largest increase in heroin treatment 
admissions were from July 2015 to August 2015, recording a 30.5% increase. Moreover, per the 
same source, from 2013 to 2015, a 127. 6% increase in the number of overdose deaths were 
registered (NHDMI, 2016). Today, non-medical use of prescription opioids is expanded, 
reaching epidemic proportions in the state of NH. 
Two walk-in-clinics in rural NH did not supply naloxone and did not possess a current 
protocol to treat patients experiencing an opioid overdose. Until this DNP project was initiated 
both clinics depended on emergency responders to administer naloxone if needed. The 
emergency responder time fluctuates; due to time of year, traffic patterns due to influx of 
tourists, weather, local events and volunteer response team availability (see Appendix A, letter 
EMS). The clinic staff was capable of pre -and post-resuscitation however, without naloxone 
availability, death can be imminent. Moreover, the clinics are closer to most of the population 
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than the hospital emergency department. The number of deaths due to opioid overdose continues 
to grow in rural NH. This DNP project has promoted education preventing non-medical use of 
prescription opioids that may result in death.  
These two clinics interact with a diverse patient population, including patients who have 
overdosed and abused prescription opioids and heroin. The nursing and healthcare providers 
raised concerns on how to administer the opioid antagonist naloxone safely and cost effectively. 
Also, the fact that there is no existing opioid overdose pre-and post-resuscitation standard of care 
in these clinics represents an important issue. Relying on only cardio-pulmonary-resuscitation 
(CPR) is not enough. 
The epidemic of opioid deaths in rural NH demands current factual, up to date 
information be translated quickly to our two rural clinics health care providers and nursing staff. 
Prompting the initiation of this DNP project, that established an evidence based knowledge of 
emergent treatment. Thus reducing deaths from opioid overdose that required quick assessment 
and intervention from nursing, nurse practitioners and physicians. New Hampshire newspapers, 
TV stations, and the NH Division of Public Health Services reported on December 7, 2015 that 
of the number of related overdose deaths in 2014 were caused by opioids (NHDPHS, 2015). The 
Concord Monitor reported that 2016 drug deaths in NH surpassed the 2015 record (Nilsen, 2016 
a).  
The NH Drug Monitoring Initiative Report of 2016 predicted greater than 500 deaths as  
a result of opioid overdose. This translates one person dying from a drug overdose every day in 
New Hampshire (NHDMI, 2016). The epidemic of overdoses and deaths associated with abuse 
of non-medical use of prescription opioids and heroin is devastating. Until recently, most by-
standers and loved ones could only stand by and wait for emergency responders to arrive and 
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hopefully resuscitate the overdosed victim, as in rural New Hampshire, some towns and counties 
rely on volunteer emergency responders. In rural NH, the local sheriff office, and local police 
departments do not carry naloxone in emergency kits. This can delay the emergency response 
time and lead to the victim’s death (see Appendix A). Under present conditions, the two clinics 
are highly exposed to risks. Nurses, nurse practitioners and physicians needed to acquire a 
standard of care that initiated proper treatment and can effectively utilize life-saving 
interventions for the person experiencing an opioid overdose.  
Need for a Protocol for Treatment and Naloxone 
Nurses and healthcare providers needed a standard of care that did through academic 
training initiate proper treatment and would utilize effective life-saving interventions for the 
person overdosing. As mentioned previously, two clinics in rural New Hampshire until the 
initiation of this DNP project did not stock naloxone, and had no pre -and post-resuscitation 
protocol for the potential overdosed patient. Both facilities have family practice providers that 
treat a large population of chronic and acute pain as well as dispense opioid prescriptions. 
Although healthcare providers are decreasing opioid prescriptive habits, the potential for a 
person abusing opioids to, present at one of the clinics exists. NHDMI (2016) reported that, not 
all physicians are willing to treat addiction with suboxone that reduces the craving for opioids, 
patients remain at high risk of overdosing and dying.  
Suboxone is prescribed by a licensed physician trained and certified to dispense the 
medication. Suboxone allows the opioid addicted individual to experience the least amount of 
withdrawal symptoms. Surprisingly, NHDMI (2016) reports that suboxone is prescribed by a few 
physicians in the state of NH, while an estimated 10,000 people in NH, might benefit from the 
treatment have no legal way to obtain the drug. According to the NHDMI (2016), NH providers 
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are some the nation’s most prolific prescribers of highly addictive painkillers, driving the state’s 
drug crisis. In 2015, over a three-month period, patients in NH filled nearly 200 thousand 
prescriptions for oxycodone and other opioids, totaling some 12 million doses representing more 
than 9 doses for every man, woman and child in NH. 
Organizational “Gap” Analysis of Project Site 
   The organizational gap analysis of this project included establishing a schedule and time 
line to implement this DNP project over three months in two rural New Hampshire clinics. 
Understanding the relationship of the non-medical use of prescription overdose patients, provider 
intervention and need to establish a reasonable clinic protocol providing nurses, nurse 
practitioners and physicians with the evidence based knowledge, skill set, and equipment to save 
lives were voiced by staffing and the community. Supplying the two-clinic code carts with 
naloxone intra nasal atomizer and knowing how to dispense it properly when needed had to 
occur in order to properly care for the opioid overdosed patient. Establishing a DNP project that 
implemented quality improvement reducing the risk of deaths associated with the daily epidemic 
non-medical use of prescription opioids overdose is a desired outcome of both rural clinics. As 
already discussed in the introduction section of this paper, a gap in care existed. This DNP 
project was centered on making change by improving nurses, nurse practitioner and physician’s 
confidence, knowledge and skill set caring for a population of patients at risk for untimely death.  
Problem Statement 
   Patients presenting to the two rural clinics with non-medical use of prescription opioid 
overdose symptoms are at risk for death. The two clinics in discussion did not possess the 
requirements to prevent death from overdose of non-medical use of prescription opioids. 
Training nurses and healthcare providers to quickly assess the overdose patient and initiate pre-
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resuscitation care along with administering naloxone intra nasal to revive the overdosed patient 
could save lives. Opioid overdose and recognizing opioid overdose is further discussed on page 
twenty-six of this DNP document. Post resuscitation that involves stabilizing the patient and 
transporting the patient to the nearest emergency department for post overdose of non-medical 
prescription opioids care can improve overall outcome. This DNP project has provided nurses, 
nurse practitioners and physicians with the knowledge and skills to utilize available equipment 
needed to reduce death from non-medical use of prescription opioids overdose in a rural clinic. 
Utilizing the NH (2015, 2.15A and 2.15P) emergency responder’s algorithm for pre-and post-
resuscitation of an overdosed patient as well as use of naloxone intra nasal administration, has 
saved lives. 
Literature Review 
   A comprehensive literature review was conducted to identify and critique interventions 
related to non-medical use of prescription opioids, the present paper utilized the following search 
engines and databases: CINAHL, PubMed, Google Scholar, and CDC web sites. Key terms 
utilized were opioid overdose, opioid pain management abuse, emergent treatment of the opioid 
overdose patient, naloxone (Narcan) intervention, and epidemic. Articles where explored for the 
best treatment options caring for an opioid overdose patient. Additionally, the materials included 
in the research are dated from 2009 through March 2016 that included all adolescents age twelve 
and older. The exclusion criteria included individuals younger than twelve and patients who were 
prescribed opioids for pain related to cancer progression; cancer produces pain at multiple levels, 
requiring fluctuating pain dosing that can exceed the standard dosing of a non-terminal patient.  
As the non-medical use of prescription opioids epidemic continues to evolve, this author 
found it is necessary to include studies dedicated to opioid prescriptive habits illustrating the 
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magnitude of the problem. Understanding non-medical use of prescription opioids abuse may 
initiate changes, which can lead to alternative pain control methods and fewer deaths. During this 
process, the author retrieved forty articles from the search engine of which twenty-eight were 
included in this literature review. As resulted from the scholarly and other articles related to 
opioid and heroin overdose reviewed, it is evident that an epidemic of abuse and deaths is 
occurring. The review tries to open an understanding towards what initiated and promoted the 
growing epidemic of the non-medical use of prescription opioids.  
During this research, many articles and guidelines were explored, including the 
recommended intervention by emergency responder’s protocol; that is the State of New 
Hampshire Patient Care Protocol (2015, 2.15A and 2.15P) for abuse/overdose. This involves pre-
and post-resuscitation interventions of the non-medical use of prescription opioids overdosed 
patient, including naloxone administration.  
The Agency for Healthcare Research Quality (AHRQ) guideline summary is as follows. 
Community management of opioid overdose (WHO, 2014) objective was designed to reduce the 
number of deaths from opioid overdose by providing evidence-based recommendations on the 
availability of naloxone for people exposed to this epidemic, along with pre-and post-
resuscitation care of the opioid overdose patients in the community. Nilsen (2016b) claims that 
NH ranks third-highest per-capita in drug deaths nationwide, falling behind only West Virginia 
and New Mexico. Because of this escalating epidemic the Board of Nursing from NH initiated 
and adopted emergency rules for opioid prescribing on 18th December 2015 (NHBON, 2015).  
Prescriber Habit and Increased Death 
   Non-medical use of prescription opioid overdose deaths is a complex issue resulting in 
negative consequences, death. A large study involving U.S. Veterans given prescriptions for 
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opioids and benzodiazepines together were investigated. The department of US Veterans tracked 
over a six-year period from 2004-2009 finding a substantial increase in opioid and 
benzodiazepine deaths. The author found an indication that provider’s prescriber patterns where 
responsible for an increased risk of deaths. The study did not include the interventions utilized by 
the U.S. Veterans except to establish that prescriber’s prescriptive patterns needed to change to 
reduce the increased of risk of death when prescribing opioids to patients (Park, Saitz, Ganoczy 
& Bohnert, 2015). Opioid prescriptions in the United States increased over the last twenty-five 
years from 76 million in 1991 to nearly 207 million in 2013 (Hawk, Vaca & D’Onofrio, 2015). 
Studies indicated that physicians poorly managed patients’ pain. Aggressive pharmaceutical 
marketing practices and promotion of affordable opioid pain medications added to the non-
medical use of prescription opioids epidemic climate. Hawk et al. (2015) also noted that with 
increased attention to pain as the ‘fifth vital sign’ and professional society guidelines based on 
risk-benefit analysis by expert consensus rather than high quality research studies, many health 
care providers embraced chronic-opioid therapy management of non-malignant chronic pain. 
Naloxone Treatment  
    In 2014, the community management of opioid overdose guideline was reviewed by the 
World Health Organization (WHO). This guideline reviews and interprets recommendations 
related to using an intervention for an opioid overdose victim. It defined the use of naloxone, and 
need for implementing it, while pre-and post-resuscitation were identified in the care of a person 
receiving naloxone. Post care was also, reviewed and established as a need to prevent further 
death from opioid overdose. Opioids are cheap, accessible, and abuse can be reached easily. As 
mentioned, the rates of opioids overdose have reached epidemic proportions, calling for a quick 
medical response, to prevent death.  
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Stephens and Tanabar (2015) found that adequate pre-hospital care hinges on aggressive 
airway control. The next intervention is utilizing naloxone either intra muscular (IM) or intra 
venous (IV) or intranasal (IN). IN route, of naloxone administration is of a similar effect to the 
IM route as a first line treatment for isolated opioid overdose in the pre-hospital setting 
(Stephens & Tanabar, 2015). A need for nurses and healthcare providers in the clinic is to 
achieve a better understanding of the necessity of being prepared and properly trained in case of 
a non-medical use of prescription opioid overdose patient, is important. Although few guidelines 
regarding this procedure were established, many studies and research became available, claiming 
that quick intervention is the key to saving lives when applying an overdose standard of care.  
A skid row area study in Los Angeles, CA measured outcome intervention of the 
overdose individuals with naloxone. This research September 2006 through 2008 involved 
training first responders, individuals with substance use disorders, and others likely to witness 
and overdose utilizing naloxone as well as pre-and post-resuscitation. At the end of the study it 
was concluded that overdose prevention and response training programs may be associated with 
improved overdose response behavior, with few adverse consequences and some unforeseen 
benefits, such as reduction in personal drug use (Wagner et al., 2009).  
The NH Medical Examiner reported that in 2013 a total of 193 deaths from drug 
overdose, 70 of these deaths were from heroin and 18 from fentanyl-a strong opioid. In 2014, the 
total drug overdoses climbed to 326 of which 293 involved a combination mix of heroin and 
non-medical use of prescriptive opioids, 439 deaths from a combination mix of heroin and non-
medical use of prescription opioids use in 2015. The Mayor for Manchester, NH had requested 
that the Governor of NH Maggie Hanson declare a state of emergency due to the opioid epidemic 
(WMUR 9, 2016). 
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As of March 2017, deaths associated with opioids and non-medical use of prescription 
opioid overdose in Manchester, NH alone is 70 with emergency responders treating 268 
overdoses. One victim was less than 15 years of age, while another at age 70. Several of the 
treated had repeated treatment with naloxone two to five times (WMUR 9, 2016). Manchester 
police and NH State Police are continuously frustrated as deaths accumulate due to the 
combination of heroin and non-medical use of prescription opioid overdoses. The deaths in NH 
correlate with the Center for Disease Control (CDC, 2016). The CDC reported that drug 
overdose was a number one cause of injury-related death in the United States with 43, 982 deaths 
documented in 2013 (CDC, 2015). The National Institute on Drug Abuse, and American Society 
of Addiction Medicine released documentation in 2016, noting the impact on special populations 
in ages 12-17. In 2014, 467 thousand adolescents were current nonmedical users of pain relievers 
with 168 thousand having an addiction to prescription pain relievers (NIDA, 2016). This same 
study reported during 2014 an estimated 28 thousand adolescents had used heroin in the past 
year, and an estimated 16 thousand were current users of heroin (NIDA, 2016). The combination 
of heroin and non-medical use of prescription opioids related overdose deaths continue to sky 
rocket in the state of NH prompting a public outcry. 
Legislature of New Hampshire 
The New Hampshire legislature passed a bill: NH HB 271 (2015) 157 (see Appendix B 
the legislation). This bill allows, health care professionals to prescribe opioid antagonist 
(naloxone intra nasal e-kits) to a person experiencing an opioid related overdose or a family 
member, friend, or another person able to assist a person at risk of experiencing an opioid 
overdose (NH, 2015). The changes in legislation and public outcry have made an impact on the 
clinics in rural NH.  This author is stationed at two different NH rural clinics; one clinic has 
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emergency responder arrival time within minutes while the other clinic depends on a volunteer 
member emergency responder arrival that can take twenty minutes and longer. This DNP project 
involved utilization of naloxone in the two clinics in rural NH and healthcare provider education 
allowing effective treatment of the opioid overdose patient that is brought to the clinic by a 
friend or family member. Currently, now both clinics do stock naloxone in their code carts.  
Code Cart 
   A code cart is a set of trays/drawers/shelves on wheels used in hospitals, urgent care 
clinics for transportation and dispensing of emergency medication/equipment at the site of a 
medical, surgical, cardiac, opioid overdose emergencies along with life support protocols to 
potentially save someone’s life. A recent article acknowledged the importance of lay person 
access to naloxone (Calas, Wilkin & Oliphant, 2016). 
Lay persons receiving kits (naloxone emergency kits) numbered 152, 283 was reported 
while 26, 463 opioid overdosed victims had received naloxone intervention (Calas, et al., 2016). 
Naloxone is an opioid antagonist used to reverse the effects of an opioid overdose (Calas, et al., 
2016). The importance of naloxone availability and route used is important. Sabzgabaee, Eizadi-
Mood, Yaraghi and Zandifar (2011) in a controlled hospital emergency environment, found 
naloxone reduced opioid and heroin overdose deaths. When the antagonist naloxone was given 
subcutaneous (SQ), intramuscular (IM) injections or intravenous (IV) to the opioid overdose 
person, they reacted with significant agitation (Sabzgabaee, et al., 2011) only 12 of the 
individuals that received IV naloxone became agitated. This agitation can produce brute physical 
energy injuring the professional healthcare team and the victim. When naloxone intra nasal (IN) 
was used, the study demonstrated no agitation from the adversary and better safe results 
resuscitating the overdose victim and fewer deaths resulted (Sabzgabaee, et al., 2011).  
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This is important for the rural clinic that is least likely to have emergency responder time 
quickly. The clinics in rural areas are closer than most hospital emergency departments. Treating 
the opioid overdosed patient in a clinic in a rural area has many challenges. The first challenge is 
to be prepared to accurately assess and treat the opioid overdosed patient. Nursing is in a unique 
position to promote, treat and prevent an opioid overdose. Nurses are encouraged to become 
active in the prevention of opioid-related overdoses and to incorporate overdose prevention into 
their daily practice (Clark, 2014). Nurses are one of the first to respond to the symptoms of 
opioid overdosing in a clinic setting.  
   Developing a nursing evidence based interventional protocol has empowered nursing 
action that can save lives. Clark (2014) indicated that overdose prevention should be 
incorporated in every day practice. This DNP project did initiate a protocol and intervention 
administering naloxone, pre-and post-resuscitation to an overdosed patient seeking treatment at 
the clinic emergently, preventing death. With the physician, nurse practitioner and nurse’s 
learned knowledge, successful intervention and redirection of this patient, during the post-
resuscitation phase can be guided to additional detox care, leading to a possible resolution of 
his/her addiction. 
 Opioid Prescription Abuse 
   Other research reviewed included the need for health care providers to change 
prescription writing habits. A survey in December noted prescriptions rose 76 million in 1991, 
219 million in 2011, and 201 million in 2013 (Anderson, 2015). A nonfatal opioid overdose 
study by Optum National Commercial Insurance company found 2, 848 individuals aged 18 – 64 
years who suffered a non-fatal opioid overdose while taking opioids for chronic non-cancer pain 
(Brooks, 2015). In addition, 91 % of those patients (2, 597) received one or more opioid 
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prescriptions in the follow up period after the overdose-median, 299 days (Brooks, 2015). Rural 
Walk in Clinics must be prepared to treat an opioid overdosed patient preventing death. A recent 
article in the Nurse Practitioner journal found that chronic pain afflicts at least 100 million adults 
in the US, which translates to about one in two adults in the entire population (Kawi, 2016). This 
prevalence is greater than the combined total of adults affected by heart disease, cancer, and 
diabetes (Kawi, 2016). Making sure chronic pain control does not lead to diversion, abuse, or 
even death is difficult and requires providers to offer and insist on close follow up care of the 
patient. As well as promoting changing prescriptive habits of healthcare professionals will 
decrease opioid overdoses and deaths. 
   If a health care provider does not monitor a patient on opioids closely, the provider can 
lose their US Drug Enforcement Agency (DEA) certification (Sheppard & Hale, 2016). Nurse 
Practitioner Whitford found herself investigated by the DEA and the Board of Nursing because 
of prescriptive practices of pain medications (Sheppard & Hale, 2016). She was investigated 
because her practice although 80% of it was primary care also, it consisted of 20% pain 
management activities. Sheppard and Hale (2016) demonstrated the importance of balancing 
pain management concerns of patients and legal issues faced by nurse practitioners. Nurse 
Practitioners are health care providers who examine patients regularly requesting pain 
intervention.  
   These facts add to the importance of monitoring patients on opioids closely and to be able 
to intervene if abuse and overdose occurs. Along with treating, saving the life of the opioid 
overdosed victim, we as healthcare providers must redirect how a patient is managed for pain 
and provide alternative safer methods. Once this is done the need for follow-up care and detox 
must be addressed. More studies are needed. As Nurse Practitioners, the responsibility to treat 
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pain effectively should also include the legal right to provide our patients who have become 
addicted accidently or intentionally to opioid medications, with the drug Suboxone, methadone 
or vivitrol and manage their withdrawal of addiction. At this time, Nurse Practitioners must rely 
on physicians licensed to dispense suboxone to initiate and care for our patients. Research 
continues to assess the best treatment options available needed to treat the opioid addicted 
patient. Nurse Practitioners continue to work with the NH State Board of Nursing for 
authorization privileges to prescribe the medication suboxone.  
Evidence Based Practice Model 
   The purpose of this quality indicator Plan Do Act Study (PDSA) model initiated a DNP 
project that has improved quick assessment of an overdose patient. The quality indicator was 
used in improving nursing, nurse practitioners and physician knowledge dispensing naloxone 
intra nasal to non-medical use of prescription opioid overdosed patients in two rural clinics. 
Nurses, nurse practitioners and physicians now follow the State of New Hampshire Patient Care 
Protocol for abuse/overdose (2015, 2.15A and 2.15P). Nursing, nurse practitioners, and 
physicians have been trained to administer naloxone intranasal spray to the overdosed non-
medical use of prescription opioid patient as needed in the two rural clinics.  
  The PDSA model incorporated four stages putting a planned change into effect. Plan is 
the change and observation stage. This change and observation included an educational power 
point review, mock codes demonstrating change in knowledge and assessment skills of nursing, 
nurse practitioners and physicians. Resulting in the timely, accurate diagnosis of the non-medical 
use of prescription opioid patient.  
The Do stage involved implementing the trying portion of this model with informal one 
on one educational review of the State of New Hampshire Patient Care protocol along with 
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demonstration use of a “dummy” naloxone intranasal spray atomizer. During stages Plan and Do 
the pre-written test had been administered to the thirty-five-participating nurse, nurse 
practitioners and physicians. During Study phase of this DNP project assessing accuracy and use 
of naloxone intranasal spray atomizer, pre-resuscitation and post-resuscitation protocols for the 
non-medical use of prescriptions opioids has been periodically reviewed. The post-written test 
was administered to the thirty-five participants and analyzed. In the final step, the researcher 
continued to monitor naloxone intranasal atomizer spray use, pre-and post-resuscitation protocol 
of the non-medical use of prescription opioids in both clinics. During the Act phase, any 
refinements had been reviewed and adjusted as needed; although none have been made at this 
time. The researcher plans to update the two clinics pre-and post-resuscitation protocols yearly. 
Project Site and Sample 
This DNP project took place in two rural New Hampshire clinics involving thirty- five 
participants that improved emergent treatment of the opioid overdosed patient that reduced a gap 
in nursing, nurse practitioner, physician knowledge to quickly assess the opioid overdosed 
patient to prevent death. Inclusion criteria included all nurses, nurse practitioners and physicians 
working in clinic 1 and clinic 2 that agreed to participate in the DNP project. Utilizing a pre-and 
post-written test, monitored demonstration, use, and administration of naloxone intra nasal 
atomizer training, and pre-and post-resuscitation standard of care to patients presenting with 
opioid overdose symptoms. Exclusion criteria were patients who are unresponsive in respiratory 
failure without a known pulse, greater than fifteen minutes. 
Twenty nurses, ten nurse practitioners and five physicians employed at the two clinics 
walk in care centers participated in the training. All participants had Basic Life Support (BLS) 
and Advance Cardiac Life Support (ACLS) certifications that were up to date. Everyone received 
OPIOID OVERDOSE                                                                                                                    21 
 
pre-and post-written tests, each test had no identification and were placed in envelopes marked 
pre-and post-written tests and locked in this student DNP file cabinet with no other access key. 
The pre-written test overall average is eight correct answers equaling 72 %. The most difficult 
questions pre-test were questions 8 and 11. Question 8 dealt with dosing of naloxone absorption, 
incorrectly answered by twenty participants. Question 11 reviewed the duration of naloxone once 
administered; ten participants did not answer the question correctly clearly demonstrating need to 
review naloxone use, administration and effectiveness. The post-written test overall average was 
eleven correct answers 99% with one 81% or nine correct questions. 
Theoretical Framework 
Putting theory into practice: Six Steps to success, the Iowa Model and the Rosswurm and 
Larrabee Model is used to implement change (Rosswurm, & Larrabee, 1999). This is a six-step 
model to facilitate needed change. Rosswurm and Larrabee change theory has six distinct stages 
that are; assessing the need for change in practice, locate the best evidence, critically analyze the 
evidence, design practice change, implement and evaluate change in practice, and integrate and 
maintain change in practice. This DNP project required adapting and initiating a new protocol 
for providers and nursing knowledge to administer nasal naloxone in the clinic.  A standard of 
care protocol administering pre-and post-resuscitation to the opioid overdose patient will 
improve patient care and prevent deaths.  
Steps in model realization 
 
Step one of the six-step model consisted of identifying that currently the two rural clinics 
in New Hampshire did not stock naloxone intra nasal and nurses, nurse practitioners and 
physicians working with patients rely on emergency medical service (EMS) response. The EMS 
response has lengthened at times especially in the tourist season. Nurses, nurse practitioners, and 
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physicians raised concern that naloxone intra nasal was not available in the two-rural clinic code 
carts. As well as lack of knowledge how to administer the naloxone intra nasal was voiced. No 
pre-and post-resuscitation protocol was available for review or reference to care for an opioid 
overdose patient. 
Step two in this change prompted identification of available standard of care protocols for 
nurses, nurse practitioners and physicians to administer intranasal naloxone. This process 
included reviewing current literature, the appropriate and best protocols available that would 
meet a standard of care saving lives during pre-and post-resuscitation of the opioid overdose 
patient. Reviewing the problem interventions and outcomes; engaging staff and providers 
promoting change in caring for the opioid overdose patient. The nurse, nurse practitioner and 
physician bias toward addiction needed to change. Understanding the obligation to be prepared, 
reinforcing prompt treatment to an opioid overdose patient coming to the rural clinic meant 
saving lives.  
Step three of this process involved review of the protocols available and critically assess 
this information. This included feasibility-use, benefits to the staff as well as patient, 
implementing the new protocols. During this process, a pre-and post-written test was developed 
to demonstrate and promote evidence based knowledge for administering naloxone intra nasal, 
recognizing opioid overdose symptoms, in order to act quickly and accurately to a presenting 
opioid overdosed patient. Recognizing the need for change and the process to make change was 
enthusiastically recognized by the nurses, nurse practitioners and physicians. 
Step four defined the proposed change, review of identifying resources, promotion of the 
capstone project that included presenting to nurses, nurse practitioners and physician’s 
information related to the timing that included scheduling of power point program, mock codes, 
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and written tests of this capstone project. During this time nurses, nurse practitioners and 
physicians had an opportunity to discuss concerns prompting open communication with the DNP 
student. Similarly, during open communication, a transformation of biased attitudes became 
empathetic and a need to promote the best treatment available was continuously voiced by the 
nurses, nurse practitioners and physicians throughout this capstone project. 
Step five included implementations of the three-month DNP project that resulted in 
change in practice. The evaluation of the pre-and post-written tests, costs of the program 
including nurses, nurse practitioner and physician time, cost of posters, pamphlets and intra nasal 
naloxone for two code carts and four “dummy’ naloxone intra nasal atomizers for demonstration 
with staffing during mock codes. 
Step six integrated a positive change in the rural clinics in New Hampshire. Nurses, nurse 
practitioners and physicians through the pre-and post-written testing demonstrated a significant 
change in knowledge and confidence administering naloxone intra nasal opioid antagonist, pre-
and post-resuscitation to an overdosed opioid patient. Step six included review of all findings to 
the administrators-stakeholders as well as all staff participating in the DNP project.  
Goals, Objectives, and Outcomes 
  This DNP project was a convenience sample of clinic staff utilizing quantitative one-
group pre-test/ post-test design establishing the benefits of a specific healthcare intervention (see 
Appendix C clinical naloxone training protocol) implemented week one through four 
consecutively for three months. Goals and objectives utilized and involved one: Development of 
a protocol for opioid overdose patients will increase nurses, nurse practitioners and physician 
knowledge needed to perform the necessary intervention to treat quickly and appropriately. Two: 
Provide availability of naloxone in two rural clinics code carts. Three: Implementation and 
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instruction, proper administering of naloxone, utilization of a pre-resuscitation and post 
resuscitation clinical protocol, so that the nurses, nurse practitioners and physicians can decrease 
risk of deaths associated with opioid abuse. The ultimate outcome of this DNP project was to 
provide evidence based knowledge, education and training that would decrease risk of deaths to 
patients who abuse opioids leading to overdose and death. 
Evidence of Stakeholder Support 
Permission to initiate this quality DNP project was granted by the governing 
administrative department of the two rural clinics in New Hampshire (see Appendix D 
permission). This educational DNP project provided nursing, nurse practitioners and physicians 
with the tools necessary to quickly treat an opioid overdosed patient and prevent death. 
Protection of Human Subjects and Ethics 
     Patient confidentiality was protected by the Health Insurance Portability and Accountability 
Act (HIPAA) as well as The Confidentiality of Alcohol and Drug Abuse Patient Records 
Regulation privacy acts. An Institutional Review Board (IRB) form was compiled and submitted 
to the University of Massachusetts-Amherst. A determination of Human Subjects form was 
submitted to UMass-Amherst and a waiver was obtained. The IRB process was reviewed by the 
University of Massachusetts-Amherst and waived (see Appendix E confirmation letter). 
When preparing this DNP project each nurse and health care provider was asked to 
review and voluntarily sign a human subject’s protection waiver prior to initiation of the research 
(see Appendix F consent). This DNP project did include a pretest and posttest written tests to 
assess nurses and healthcare provider’s knowledge (see Appendix G pre-post written tests), how 
to administer naloxone and initiate pre-and post-resuscitation protocol if an opioid overdose 
patient presents at either rural New Hampshire clinics. No identifying name was assigned to the 
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written pretest or posttest, educational demonstrations of naloxone and the pre- and post-
resuscitation protocol implementation utilization of all educational tools during hands/on 
educational/demonstrational sessions. All nurses, nurse practitioners and physician’s human 
rights have been protected. 
Anonymity of the highest degree was observed where each participant was assigned a 
code, written pretests and posttests were coded and not identifiable by name. All materials were 
kept in a locked and secure file in the researcher’s office. Consent forms were not stored with the 
pre-test and post-test. Only the researcher and university research team members had access to 
evaluations. Information from this project has been presented in summary format and they will 
not be identified in any publications and presentations. All participants were informed (full 
disclosure) prior to participation in this DNP project, they were given an opportunity to ask 
questions, as to what was involved in the educational DNP project, the right not to participate, 
the right to withdraw from the project training and withhold information from this project at any 
time. 
Clinic Standard of Care 
This DNP project is designed to save the life of opioid overdosed individuals. Use of 
naloxone, pre-and post-resuscitation has been offered to our nurses, nurse practitioners and 
physicians working at clinic 1 and clinic 2. In addition, special public educational offerings at 
both clinics will be provided for non-clinic physicians, nurse practitioners, nurses, support 
staffing, family members, friends of those with known addiction, and the public. The added 
educational offerings will be presented by professionals involved in the treatment and care of the 
addicted. Understanding opioid overdose and recognizing the symptoms of an opioid overdose 
can reduce death.  
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Opioid Overdose  
     An overdose occurs when the body has more drugs in its system than it can handle, resulting 
in potentially life threatening changes. The body metabolizes opioid overdosing which affects 
how we breathe. Decreased ability to breathe causes a lack of oxygen and increased risk for 
dying. An opioid overdose impacts breathing and slowly the individual stops breathing. (the 
amount of opioid taken does affect how long it lasts in the body). Respiratory depression is 
reversible until death occurs, this can take one to three hours and can be reversed with naloxone, 
which displaces opioids from the opioid receptor and blocks the binding of additional opioids for 
thirty to ninety minutes. It has been documented that CPR alone is not enough to reverse an 
opioid overdose.  
Recognizing Opioid Overdose 
The effects of a non-medical prescription opioid overdose are threefold. Often the 
individual is unconscious or has reduced consciousness; shows pinpoint pupils, and suffer 
respiratory depression. If an opioid overdose is not treated, a person will stop breathing, go into 
cardiac arrest and die. An opioid overdose is a dire medical emergency. A table describing 
symptoms of being opioid high and opioid overdosed is presented in the supplementary 
documents (see Appendix H opioid symptoms).  
Cost Benefit Analysis 
This DNP project utilized life saving measures. Multiple studies defined the dollar 
amount for caring for an individual that has overdosed on opioids can run in the tens of 
thousands of dollars. The time involved in court, lost wages as well as incarceration, treatment 
remains costly to the opioid addicted patient, his or her family and employers.  Birnbaum et al, 
(2011) found evidence that prescription opioid abuse is an increasing and substantial burden on 
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society as a whole. “Criminal justice costs contributed approximately $5.1 billion, or 9.2% of the 
total societal costs, of which correctional facilities accounted for the largest share with $2.3 
billion (44.1%)” (Birnbaum, et al., 2011). Often the opioid addicted patient cannot work, 
becomes a dependent of the state as well as any dependent children. As this epidemic grows so 
do the financial burden to properly care for this patient and his or her family. In-patient detox 
centers are few and have long waiting lists and often not covered by health insurance. New 
Hampshire economy lost 1.85 billion due to substance abuse in 2012 (McDermott, 2014). As the 
number of near miss and fatal opioid overdose increases, so will the cost to treat these 
individuals and the families left behind. 
Resources 
Three thousand dollars was allotted by the budget committee of the practice and voted on 
by owners and partners of this clinic to implement lifesaving education, demonstration and use 
of opioid overdose protocol for the two rural clinics in New Hampshire (see Appendix I budget). 
This DNP project utilized the entire budget during this three-month training period. Nurses, 
nurse practitioners and physician’s hourly distribution of funds totaled $2,500.00. Opioid 
overdose wall posters for two clinics printing expenditure was $100.00. Lamination of the opioid 
pre- and post-resuscitation (NH, 2015, 2.15A and 2.15P) protocol was placed in the two code 
carts for easy review when needed, totaled $100.00.  $200.00 paid to medical supply house for 
naloxone intra nasal for two code carts and four “dummy” naloxone intra nasal atomizers for 
training demonstration. An additional out of pocket expense of $ 67.00 for printing pamphlets- 
How to Avoid Overdose (See Appendix J rescue breathing pamphlet) for both rural clinic 
waiting rooms accrued by this DNP project trainer. 
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Methods 
A pre-test was administered followed by observational nursing, nurse practitioners and 
physician’s demonstration and use of naloxone intra nasal administration. Initiation of pre-and 
pose-resuscitation care during mock codes, is intended to build participants level of knowledge, 
confidence and satisfaction caring for an opioid overdosed patient had been reviewed as well as a 
post-written test. Education of Clinic Staff December 2016: An all staff meeting was assembled 
to invite all nurses, nurse practitioners and physicians employed in the two clinics to participate 
in an all staff meeting that included the following, a power point program demonstrating the need 
to be prepared to care for an opioid overdose patient. This educational program identified the 
New Hampshire current epidemic crisis and need to accurately identify and treat the opioid 
overdose patient, preventing death. 
Project Design 
A pretest was administered to participating nursing, nurse practitioners at the clinic to 
evaluate knowledge of Naloxone use and a post test was administered after to evaluate the 
effectiveness of this educational intervention. This post-test was given to the same nurses, nurse 
practitioners and physicians to evaluate if after receiving education through a power point 
education program, mock codes, one on one administration demonstration of naloxone intra 
nasal opioid antagonist was changed. This DNP project was designed to address and change 
nursing, nurse practitioners, and physicians care for an opioid overdose patient. 
After the implementation of nursing and healthcare provider education, a pre-and post-
resuscitation protocol for opioid overdose patient has been added to both clinics. This has been 
placed in laminated format at the site of both Code Carts for immediate retrieval as needed. 
Included is the recommended naloxone dosing enabling nursing and healthcare providers 
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evidence based protocols-State of New Hampshire Patient Care Protocol (2015 section 2.15 A 
and 2.15 P) to intervene and save lives. Each code cart has a standard supply of naloxone intra 
nasal 2mg/2ml Leur-lock prefilled disposable syringe (instruction included) (Epocrates Rx., 
2017) to use as needed for the opioid overdosed patient, to prevent death.  
Training of nurses and healthcare providers starting December 2016, included: 
• Week one: pretest, review of naloxone administration for the opioid overdose patient 
clinic protocol. 
• Week two: nursing and healthcare provider demonstration of naloxone administration and 
opioid overdose clinic protocol (mock code scenario). 
• Week three: review of nursing and healthcare provider concerns, critique using naloxone 
and opioid overdose protocol. 
• Week four: posttest. Make changes if needed. Repeat for a total of 3 months until all 
clinic nurses and healthcare providers are trained in naloxone and opioid overdose 
protocol use. 
Setting 
This DNP project took place in two clinics in rural New Hampshire. The nursing staff 
and providers care for a diverse group of patients from chronic to acute care. At any time, a 
patient who is unresponsive from an opioid overdose crisis may present at both clinics requiring 
quick assessment and treatment. Some patients in an opioid overdose come to the clinics either, 
brought by friends or family members. The clinics’ nursing staff is often the first to assess an 
overdose patient. Quick intervention by nursing staff and providers is crucial to saving lives.  
Until recently the cost of stocking medications with a short shelf life could be expensive. 
Research has proven that naloxone is necessary to revive an opioid overdose patient along with 
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pre- and post-resuscitation. The explosion in opioid overdoses has increased public as well as 
nursing and provider awareness. Nurses and providers want to prevent death while providing 
crucial pre-and post-resuscitation care. 
Results 
     Educational seminars and training in both clinics were provided by the DNP student who is a  
nurse practitioner who is a licensed provider in the state of NH promoting quality nursing  
competency within her nursing scope of practice. Allowing utilization of the best evidence based 
research available to maintain quality healthcare to our overdosed patients in our care. This has 
taken place over a three-month period at both clinics, December 2016 through February 2017.  
     A IBM SPSS 24 statistical t test and mean statistical evaluation of the program was utilized to 
define the significance of the nurses, nurse practitioners and physician’s knowledge post-written 
test and training to care effectively of the opioid overdose patient. Average percentage pre-testing 
was 72% and post-testing was 100% for thirty-four of the thirty-five participants with one 
participant (81%). A Mean test was performed as reviewed in this section, paired samples 
correlations and paired samples statistics formulations tables are as follows. 
Figure 1: Scatter Plot of Pre-test Scores 
Number of Participants (35) Who Completed the (11 question) Written Pre-Test 
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     The pre-written test results scatter plot revealed questions pictured above starting with 
question 10 demonstrated, ten of the thirty-five participants did answer question 10 correctly. 
Next is question 11 noting thirty of the thirty-five participants responding correctly. Questions 1, 
3, 4, 5, 6, 7 and 9 all thirty-five participants responded correctly. Question 2 demonstrated thirty 
of the thirty-five participants answered correctly. And question 8, twenty of the thirty-five 
participants answered this question correctly.  Questions can be reviewed in Appendix G see pre-
post test questions. 
Figure 2: Scatter Plot of Post-test Scores 
Number of Participants (35) Who Completed the (11 question) Written Post-Test 
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     The post-written test overall average was eleven correct answers equaling 100% for the thirty-
four of thirty-five participants with one participant demonstrating incorrect answers for question 
8 and 9 (81% score).  
      The Scatter Plots Figure 1 and 2: pre-and post-testing demonstrate notable variations in 
scoring of the 35 participants (nurses, nurse practitioners and physicians) employed at two rural 
health clinics: pre-written and post-written test. Testing utilized in this DNP project 
demonstrated evidence based knowledge pre-and post-demonstration of naloxone intra nasal 
administration and pre-and post-resuscitation of the opioid overdose patient.  
Table 1: Mean Testing Pre-and Post-test. 
 N=11 Pre-test Post-test 
Mean 8.20200 0.40452 
   
      N= 11 for number questions each participant answered. Pre-test descriptive measures (mean)  
was measured for pre-and post-testing questions using the SPSS format resulting in a high of  
8.20200 and post-test mean low of 0.40452. This is a significant improvement in participant  
33.8
34
34.2
34.4
34.6
34.8
35
35.2
0 2 4 6 8 10 12
N
u
m
b
er
 p
ar
ti
ci
p
an
ts
Questions 1-11
Post-test scores
OPIOID OVERDOSE                                                                                                                    33 
 
scoring pre-and post-written testing as demonstrated visually in Figure 1 and Figure 2.   
Table 2. Paired Sample Statistics. 
Pair 1 Written Test Mean N Std. 
Deviation 
Std. Error 
Mean 
 Pre-Test 30.4545 11 8.20200 2.47299 
 Post-Test 34.8182 11 0.40452 0.12197 
 
Table 3. Paired Samples Test                         
  Mean SD SEM Lower Upper t df Sig 2T 
Paired 
1 
Pre-
post 
-
4.3636 
8.1396 2.4542 -
9.8319 
1.1046 -1.778 10 0.106 
 
(SD=Std. Deviation, SEM=Std. Error Mean, 95% CI of Difference, Sig 2 tailed). 
      Table 2 and 3: paired-t differences had a notably significant difference in the scores for pre-
written test (M=30.4, SD=8.2) and post-written testing (M=34.8, SD=0.40) conditions t (10) =-
1.77, p=0.106. These results suggested that the post-written test taken by nurses, nurse 
practitioners and physicians was higher. The pre- and post-written testing utilized in this DNP 
project demonstrated notable changes that demonstrated effective change in learned knowledge 
caring for non-medical use of prescription opioid overdose patients.    
Conclusion 
 This DNP project demonstrated a need for change in the way nurses and physicians 
handled opioid overdose patients. This project took place in two rural walk in clinics. Translating 
evidence based knowledge increased understanding by nursing, nurse practitioners and 
physicians the ability to administer opioid overdose patient treatment accurately, timely, and 
proficiently, thereby preventing death. 
The major epidemic in rural New Hampshire continues to explode daily. You can turn on 
the TV, read the newspaper, listen to the radio, legislators in New Hampshire are voicing 
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concerns and continue to search for change. Action includes all clinic nurses; healthcare 
providers need to be well equipped and prepared to intervene quickly assessing and caring for 
the opioid overdosed patient. Dissemination of reinforcement of nurses and healthcare provider’s 
new knowledge will facilitate better preparedness and knowledge that improves success in 
treating the opioid overdose patient and reducing death. Dissemination is an important 
component of translation of evidence, because if the translation is not disseminated, then no 
change in care will occur, and innovations will not be adopted (White & Dudley-Brown, 2012).  
What is the social injustice related to opioid abuse and why should this matter? Opioid 
misuse both prescription and nonprescription poses significant risks for contacting HIV and 
Hepatitis, leading to other health problems (NH DHHS, 2014). The average age of those that 
died from an opioid overdose in New Hampshire for 2013, 2015, and 2016 was 20-29 years old 
for both male and females. New Hampshire hospitals reported significant increases in the 
number of babies being born with symptoms of opiate withdrawal related to maternal drug use. 
Babies suffer extreme pain, respiratory, cardiac and gastrointestinal compromise during 
withdrawal, some babies are not strong enough to overcome the deteriorating effects of 
withdrawal and die. Opioid addiction does not discriminate by race, age, gender or 
socioeconomic status. Your best friend could be addicted and you would not necessarily know as 
often the addicted person takes enough of the opioid to feel and act as their normal self. 
Unfortunately, they become tolerant of that dose and soon require more and more of the drug; 
they are unable to work and loose access to health care and seek other methods to obtain the 
opioid needed to make it through each day. Their families get fed up with the drug seeking 
behaviors, they lose legal custody of their children, friends walk away in disgust, and then they 
OPIOID OVERDOSE                                                                                                                    35 
 
overdose and die. New Hampshire and United States could lose a whole generation; the majority 
of them ages 20-29 years. 
In the two clinics in rural New Hampshire promoting life saving strategies and 
developing effective protocols is the start to reduce opioid overdose deaths. A quality 
improvement DNP project has brought change to the practice as well as encouraging and 
promoting counseling for known addiction patients. Providing information and referrals to 
addiction counseling could be achieved through this DNP. Other benefits of the DNP project 
include, cautiously dispensing of opioids for acute pain and counsel patient to addictive potential 
as well as prescribing alternative therapy for acute and chronic pain. When alternative therapy 
such as massage and physical therapy are not effective, a limited use of an opioid for short term 
use with weekly monitoring by the healthcare provider should be considered. As previously 
stated this DNP project pre-testing, training and post testing demonstrated nurses, nurse 
practitioners and physician’s once given the evidence based education could confidently 
disseminate and translate knowledge into action. The goal of this DNP project improved nursing, 
nurse practitioners and physician’s confidence knowledge and skills allowing for accurate 
diagnosis and treatment of the opioid overdose patient reducing the risk of death.  
As researchers continue investigating the best quality, quick assessment and care for the 
opioid overdose patient the result for this patient hinges on who is administering the care, 
availability of naloxone as well as knowledge to implement care.  
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Appendix A 
Letter EMS 
BARTLETT/JACKSON AMBULANCE SERVICE 
REPORT 2015  
  
The year 2015 found Bartlett Jackson Ambulance Service at par with last year, slightly above the 
500 call mark. The average call still takes about two hours from start to completion. Better 
documentation programs has sped this up a bit.   
  
Bartlett Jackson Emergency Medical Services acts as a clinical site for SOLO and continues to 
be a great success! Several students have joined our service and we continue to encourage them 
to become involved in their own community wherever that may be.  
  
Bartlett Jackson data collection regarding mTBI continues and is entering its third year. This is 
an effort to identify concussions in the early stages in order to provide the most appropriate 
treatments. This is a blind study that identifies the injury, how quickly it was recognized and the 
follow up care. Patients and schools have responded very well to the efforts put into this 
program. We are currently exploring ways to work with pediatric physicians regarding 
concussion injuries in younger children.  
  
Motor vehicle accidents and structure fires continue to keep our members busy as well. Calls that 
result in standing by to support police officers have risen slightly over the past few years. This 
includes local police, as well as County Sheriffs and the NH State Troopers.  
  
Opiate misuse continues to be an issue through the United States, and New  
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Hampshire is no exception. We are working with the Mount Washington Supports Recovery 
group and have participated in a Narcan training open to the public. Our goal is to make a 
positive impact and reduce substance addictions in our community.  
  
Billing continues to be challenge as patients often change carriers yearly.  
We have made a significant improvement gathering insurance cards at the times of service.  
  
Bartlett Jackson EMS continues to develop community relations with a cooperative agreement 
with the VNA of Mt. Washington Valley. This is an effort to allow patients to remain in their 
homes and enjoy their quality of life, and results in lower health care costs. We offer lift 
assistance and suggestions as to where products such as power chairs and grab rails can be 
purchased, and occasionally, who patients can contact to assist in the installation of these 
products.   
  
Bartlett Jackson EMS currently has five members in college and universities that are active 
members. Most of these students are pursuing careers in medicine.  
These include Physician Assistant, , Pre Med, and advanced EMT and fire fighters.  
We are proud to have helped launch many medical careers over the the years! This includes 
MDs, DOs, PAs, BSN, MSN and Paramedics that are currently working in the Valley that got 
their start with BJAS.   
  
 I would like to thank the towns of Bartlett and Jackson, the citizens of both towns and the folks 
of Harts Location for their support; we can't do this without You!  
  
Thank you New Hampshire Fish and Game and the New Hampshire State Police from Troops E 
and F for all you do to keep us safe in both the urban and wilderness settings. We would also like 
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to thank Bartlett Fire, Jackson Fire, Bartlett Police, Jackson Police, Carroll County Sheriffs 
dispatch and officers for all their efforts. Also, to Memorial Hospital and Saco River Medical 
group for your trust and support in BJAS. Thank you to the AMC for sharing your personnel as 
well as Attitash, Jackson Ski Touring, Black Mt. patrollers, SOLO, and US Forrest Service. 
Working with all of you in back country injuries has always been a pleasure.  
  
Respectfully submitted,  
Signed form can be viewed on line at: www.Bartlett/JacksonAmbulance/report2015.  
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Appendix B 
New Hampshire Legislature 
NH HB 271 (2015)157 June 2, 2015 (a) A health care professional authorized to prescribe an 
opioid antagonist may prescribe, dispense, or distribute, directly or by standing order, an opioid 
antagonist to a person at risk of experiencing an opioid-related overdose or a family member, 
friend, or other person in a position to assist a person at risk of experiencing an opioid-related 
overdose. Any such prescription shall be regarded as being issued for a legitimate medical 
purpose in the usual course of professional practice. (b) A person or organization may, if acting 
pursuant to the provisions of subparagraph (a), store and possess an opioid antagonist, dispense 
or distribute an opioid antagonist, and administer an opioid antagonist to another person who the 
person believes is suffering an opioid- related overdose. (c) No health care professional who, 
acting in good faith and with reasonable care, prescribes, dispenses, or distributes an opioid 
antagonist directly or by standing order and no person who, acting in good faith and with 
reasonable care, stores, dispenses, or distributes an opioid antagonist or administers an opioid 
antagonist to another person who the person believes is suffering an opioid-related drug overdose 
shall be subject to any criminal or civil liability, or any professional disciplinary action, for any 
action authorized by this paragraph or any outcome resulting from an action authorized by this 
paragraph. (d) In this paragraph: (1) “Opioid antagonist” means any drug that binds to opioid 
receptors and blocks or disinhibits the effects of opioids acting on those receptors. (2) “Opioid-
related drug overdose” means a condition including, but not limited to, extreme physical illness, 
decreased level of consciousness, respiratory depression, coma, or death resulting from the 
consumption or use of an opioid, or another substance with which an opioid was combined, or 
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that a layperson would reasonably believe to be an opioid-related drug overdose that requires 
medical assistance. 
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Appendix C 
Clinic Naloxone Training Protocol 
Training of nurses, healthcare providers include: 
Week one: pretest, review of naloxone administration and non-medical prescription use of opioid 
overdosed patient clinic protocol. 
Week two: nursing and healthcare provider demonstration of naloxone administration and opioid 
overdose clinic protocol (mock code scenario). 
Week three: review of nursing and healthcare provider concerns, critique using naloxone and 
opioid overdose protocol. 
Week four: posttest. Make changes if needed. Repeat for a total of 3 months until all clinic 
nursing and healthcare providers are trained in naloxone and opioid overdose protocol use.   
Purpose:  
This protocol specifies the criteria and procedures for nurses and healthcare providers to initiate 
emergent opioid overdose treatment employed by two rural clinics in New Hampshire. 
Naloxone is an opioid antagonist that is used to reverse the effects of opioids.  
Current research has determined that naloxone administration has been found to prevent death 
from opioid overdose as well as reduce disability and injury from an opioid overdose. 
The rapid administration of naloxone may be life-saving in patients experiencing an opioid 
overdose. ((Doe-Simpkins, Walley, Epstein, & Moyer, 2009).  
Criteria: 
Persons eligible to receive naloxone under this protocol include: 
All individuals presenting to the clinic with opioid overdose symptoms. 
Drug: Naloxone    Route: Intranasal only  
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Indication: Nurses, healthcare providers may administer naloxone to a person in the event of 
respiratory depression, unresponsiveness, or respiratory or cardiac arrest when an overdose from 
opioid is suspected of an individual / patient presenting at the clinic.  
Procedure: 
Check to see if individual/patient breathing, If not initiate rescue breathing, call for help, 
have someone call 911, get naloxone from code cart, AED, ambu bag, oxygen. 
Assessment: ABC’s Airway, Breathing, Circulation.  
a. For pulseless individuals, initiate CPR per BCLS, guidelines. 
b. Apnea with pulse: establish airway and begin rescue breathing. 
c. Check for foreign body in airway, level of consciousness or unresponsiveness very low 
respiratory rate or not breathing, no response to sternal rub, respiratory status, gasping for 
air while asleep or odd snoring pattern, pale or bluish skin, slow heart rate, low blood 
pressure, no response to sternal rub. Pin point pupils any track marks may be present, 
although absence of these findings do not exclude opioid overdose.  
d. Level of consciousness 
1. The nurse / healthcare provider determines that the person presents with a decrease 
level of consciousness as evidenced by: 
2. Difficult to arouse (responds to physical stimuli but does not communicate or follow 
commands, may move spontaneously). 
3. Unable to arouse (minimal or no response to noxious stimuli, does not communicate 
or follow commands).  
e. Respiratory status 
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1. The nurse /healthcare provider determines that the person presents with a depression 
of respiratory status as evidenced by: 
2. Decreased respiration rate 
3. Utilize pulse oximetry if available 
4. Nurse/healthcare provider determines need for naloxone administration 
     f.   Administration: Intranasal naloxone 
1.         Assemble naloxone vial and intranasal atomizer 
2.         See Appendix J (rescue breathing and administration of naloxone). 
            Spray half (1 ml) of the naloxone in one nostril and the other half (1 ml in the    
     other nostril for a total of 2 mg). 
     g.   Continue Rescue Breathing     
1.      Continue rescue breathing or BLS as needed. 
2.      If no response in 3-5 minutes an additional dose may be administered of the   
     naloxone intra nasal spray. 
3.      Naloxone duration of action is 30 to 90 minutes. 
4.      Pt should be transferred to nearest hospital emergency room for post resuscitation   
     care and treatment. 
Considerations: Withdrawal can be unpleasant: Person may just breathe but not have full arousal, 
person may need continued rescue breathing and support. Do not leave alone. 
Document event and treatment per clinic protocol. 
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Appendix D 
Clinic Permission to implement capstone project: 
Original copy in office Administration. 
Permission has been granted to Geraldine Lau Family Nurse Practitioner to implement a non-
medical use of prescription opioid overdose standard of care for our two rural clinics in New 
Hampshire.  A budget of $3,000.00 will be at her disposal as needed to implement training of 
naloxone IN administration, and the development of a pre- and post-resuscitation protocol caring 
for the non-medical use of prescription opioid overdosed patient.  
 
Subject:  
1. Naloxone IN use and administration  
2. Stocking code cart with IN naloxone  
3. State of NH standard of care:  
pre- and post-resuscitation of the non-medical use of prescription opioids individual.  
Training to be completed within three months of initiation.  
Signed copy of this form on file in office for reviewing. 
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Appendix E 
University of Massachusetts Amherst Human Research Protection 
University of Massachusetts Amherst Human Research Protection Office 110 Research 
Administration Building Research Compliance 70 Butterfield Terrace Amherst, MA 01003-9242 
Telephone: 545-3428 FAX: 577-1728 
MEMORANDUM To: Geraldine Lau, Nursing From: Human Research Protection Office Date: 
November 29, 2016 Project Title: DNP Capstone Project: Non-Medical Use of Prescription 
Opioids Overdose Treatment in a Rural Clinic IRB Number: 16-146 The Human Research 
Protection Office (HRPO) has evaluated the above named project and has made the following 
determination: The activity does not involve research that obtains information about living 
individuals and therefore does NOT require IRB review and approval. The activity does not 
involve intervention or interaction with individuals OR does not use identifiable private 
information and therefore does NOT require IRB review and approval. The activity is not 
considered research under the human subject regulations (Research is defined as “a systematic 
investigation designed to develop or contribute to generalizable knowledge.) and therefore does 
NOT require IRB review and approval. The activity is determined to meet the definition of 
human subject research under federal regulations and therefore DOES require submission of 
applicable materials for IRB review. For activities requiring review, please see our web pages for 
more on types of review or submitting a new protocol. For assistance, do not hesitate to contact 
the Human Research Protection Office at 545- 3428 for assistance. 
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Appendix F 
Consent Form for Participation in a Research Study 
University of Massachusetts Amherst 
 
 
Researcher(s):  Geraldine Lau FNP partial requirement of a DNP degree. 
                                                     Mentor Heidi Root MD 
Study Title:   Non-medical use of prescription opioid overdose: Treatment in 
a Rural Clinic. 
Funding Agency:               No funding elicited. 
 
 
1. WHAT IS THIS FORM? THIS IS A HUMAN SUBJECTS PROTECTION FORM.  
This is a human subject’s form requesting your participation in a quality DNP project that 
promotes: A new life-saving protocol enabling nursing and healthcare provider’s educational 
information to administer naloxone to non-medical use of prescription opioids overdose 
individuals an intervention preventing death.  
 
2. WHO IS ELIGIBLE TO PARTICIPATE.  
This training is designed especially for nursing and healthcare providers employed in two rural 
New Hampshire clinics that do not currently stock naloxone or have a defined non-medical use 
of prescription opioid overdose protocol to save lives. 
 
3. WHAT IS THE PURPOSE OF THIS STUDY?  
The purpose of the study is to educate nursing and healthcare providers in two rural clinics how 
to administer naloxone intranasal and administer pre- and post-resuscitation care to a non-
medical use of prescription opioids overdosed patients that may present at our clinics.  
 
4. WHERE WILL THE STUDY TAKE PLACE AND HOW LONG WILL IT LAST? 
This educational training will take place in two rural New Hampshire clinics owned by Saco River 
Medical Group, one in Conway, NH and the other in Glen, NH. The training is expected to last 
three months in total.  
 
5. WHAT WILL I BE ASKED TO DO? 
 If you agree to take part in this study, you will be asked to participate in a written pre-and 
posttest. 
You will also participate in a pre-training demonstration administering naloxone and participate 
in mock code administering pre-and post-resuscitation to a non-medical use of prescription 
opioids overdosed patient.  
 
6. WHAT ARE MY BENEFITS OF BEING IN THIS STUDY?  
Hoped direct benefits to the participant that may be reasonably expected as a result of the 
research, includes added nursing and healthcare provider knowledge promoting confident 
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administration of the drug naloxone intra nasal and treatment of the non-medical use of 
prescription opioids overdose patient using a evidence based pre- and post-resuscitation 
intervention preventing death.   
 
7.  WHAT ARE MY RISKS OF BEING IN THIS STUDY?  
There are minimal risks associated with this DNP project educational training. At times, you may 
feel uncomfortable with this length of the training or taking the surveys, but you may decline 
answering questions on the pre-and post-written testing. At any time, you may decline 
participation in the educational DNP project.  
 
8. HOW WILL MY PERSONAL INFORMATION BE PROTECTED?  
Each participant will be assigned a code. Written pretests and posttests will be coded and not 
identifiable by name. All materials will be kept in a locked and secure file in the researcher’s 
office. Consent forms will not be stored with the pre-test and posttest. Only the researcher and 
university research team members will have access to evaluations. Information from this project 
will be presented in summary format and you will not be identified in any publications and 
presentations.  
 
9. WILL I RECEIVE ANY PAYMENT FOR TAKING PART IN THE STUDY?  
No payment is given as participation in the DNP educational training project.  
 
10. WHAT IF I HAVE QUESTIONS? 
Take as long as you like before you make a decision. We will be happy to answer any question you 
have about this study. If you have further questions about this project or if you have a research-
related problem, you may contact the researcher Geraldine Lau FNP at 603-327-7463. If you 
have any questions concerning your rights as a research subject, you may contact the University 
of Massachusetts Amherst Human Research Protection Office (HRPO) at (413) 545-3428 or 
humansubjects@ora.umass.edu. 
 
11. CAN I STOP BEING IN THE STUDY? 
You do not have to be in this study if you do not want to. If you agree to be in the study, but later 
change your mind, you may drop out at any time. There are no penalties or consequences of any 
kind if you decide that you do not want to participate. 
 
12.WHAT IF I AM INJURED? 
The University of Massachusetts does not have a program for compensating subjects for injury 
or complications related to human subject’s research, but the study personnel will assist you in 
getting treatment. 
 
13. SUBJECT STATEMENT OF VOLUNTARY CONSENT 
When signing this form, I am agreeing to voluntarily enter this study. I have had a chance to read 
this consent form, and it was explained to me in a language which I use and understand. I have 
had the opportunity to ask questions and have received satisfactory answers. I understand that I 
can withdraw at any time. A copy of this signed Informed Consent Form has been given to me. 
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________________________  ____________________  __________ 
Participant Signature:   Print Name:    Date: 
 
 
By signing below I indicate that the participant has read and, to the best of my knowledge, 
understands the details contained in this document and has been given a copy. 
 
_________________________    ____________________  __________ 
Signature of Person   Print Name:    Date: 
Obtaining Consent 
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Appendix G 
 
Written pre-posttest: Naloxone IN administration to a non-medical opioid overdosed 
patient. 
1. What is the first assessment of this patient? 
A. Is he/she breathing? 
B. He/she sleeping? 
C. He/she is smiling at you? 
2. If not breathing? 
A. Call for help? 
B. Start rescue breathing? 
C. Shake patients shoulder? 
3. Should you call/have someone call 911? 
A. Yes 
B. No 
4. Which is the most suggestive signs of opiate overdose? 
A. Violent aggressive behavior? 
B. Depressed respirations, pale, clammy skin, gurgling, snoring, non-responsive, 
slow heart rate, slow pulse if any, blue lips or fingertips (cyanotic)? 
5. What do you do first if unresponsive and probable opioid overdose? 
A. Rescue breath? 
B. Call code/call 911? 
C. Administer naloxone, intranasal spray? 
D. All above? 
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6. What is naloxone? 
A. Not sure. 
B. Opioid antagonist.  
7. How do you administer Naloxone IN (intranasal)? 
A. Intranasal? 
B. Orally? 
8. Which of the following doses will likely result in the highest amount of naloxone 
absorption in the blood stream? 
A. Dose 0.5 mg: concentration 1mg/ml; volume 0.5 ml atomized into the nare? 
B. Dose 0.8 mg: concentration 0.4mg/ml; volume 2 ml; delivery method 1 ml 
atomized into each nare? 
9. What are common reasons that a nasally applied drug might not be effective? 
A. The medication concentration is to low, requiring high volumes to obtain proper 
dosing. 
These high volumes then run out the nose and cannot be absorbed. 
B. The patient’s mucosa is covered with blood or mucus preventing absorption of the 
administered medication. 
C. All above.  
10. True or False? Which is a relatively long-lasting narcotic antagonist? 
A. Naloxone? 
B. Nalmefene? 
11. What is the duration of naloxone IN once administered? 
A. Four hours?    B. 30 to 90 minutes? 
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Appendix H 
Opioid Symptoms 
Opioid High Opioid Overdose 
Muscles relaxed Pale, clammy skin 
Speech slowed/slurred Decreased breathing/not breathing 
Sleepy appearing Deep snoring/gurgling 
Responsive to stimuli (shaking, sternal rub, 
yelling) 
Not responsive 
Normal heart beat / pulse Slow heart rate/ slow pulse/none 
Normal skin tone Blue lips and or fingertips (cyanotic) 
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Appendix I 
Budget 
Training costs estimated for two rural clinics in New Hampshire. 
Training of pre- and post-resuscitation of the opioid overdosed patient for nurses, nurse 
practitioners and physicians. 
 
1. Training hours for twenty nurses, ten nurse practitioners, and five physicians. 
 
        RN’s: $24 x 10 =         $240.00  
        LPN’s:$18 x 10 =        $180.00 
        NP’s:  $90 x 10 =         $900.00 
        MD’s:$110.00 x 5 =    $550.00    
 
A. Purchasing emergency naloxone kits for code carts and wall mounted naloxone kits. 
 
1. Five wall mounted kits at $100.00 each (each kit contains gloves, nasal naloxone  
 
atomizer with instruction for use and mask).  This is a plastic tie locked mounted box. 
 
2. Replacement supply kits for each wall unit: $20.00 (this is naloxone nasal atomizer). 
 
3. Three code cart naloxone nasal atomizer kits: $75.00 each equaling $225.00. 
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4. Code card replacement naloxone nasal atomizer is $20.00 each.  
 
B. Exam room posters related to opioid overdose promoting open communication with nurses, 
 
 nurse practitioners and physicians. 
 
1. Opioid posters $ 10.00 x 20 = $ 200.00 
 
C. Unexpected costs will include BLS and ACLS training for those nurses, nurse  
 
practitioners and physicians not certified or up to date on current certification. 
 
1. Three participants $ 200.00 = $ 600.00 
 
Estimated total initial budget: $3,000.00       
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Appendix J 
Poster rescue breathing administration of naloxone: Also placed in clinic waiting rooms.  
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